F05 F09 F03
Conditions
Interventions
Group 1: In-patients of the University Hospital Jena aged 60 and older will be assessed using standardized scores for delirium, its major risk factors and presence of dementia. After 6 months, patient
Sponsors
Universitätsklinikum Jena
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: Necessity of in-patient care in a department of the university medical center
Exclusion criteria
Exclusion criteria: in-patients of the psychiatric clinic
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In this study, all in-patients of the University Hospital Jena aged 60 years and older will be included. They will be examined in a standardized assessment for delirium and its risk factors as well as for dementia. In a one day survey, general data of the patients and the current hospital stay will be collected. Alertness will be assessed by the Richmond Agitation and Sedation Scale (RASS), patients with delirium will be identified by the Confusion Assessment Method (CAM) on general wards and by the CAM-ICU in intensive care units. | — |
Secondary
| Measure | Time frame |
|---|---|
| For determination of risk factors for delirium, following parameters will be investigated within the one day survey: presence of infection, creatinin elevation, derangement of electrolytes or blood sugar level, existence of an urethral catheter. Furthermore, the following scores will be used: Identification of Seniors at Risk (ISAR) for general risk factors for a worse outcome, Montreal Cognitive Assessment (MoCA) for cognitive performance, SOF-Frailty-Index (Study of Osteoporotic Fractures) to determine frailty and the chair rising test to determine mobility. The one day survey will be followed by an interview of the patients’ relatives with the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as an external judgement of the cognitive performance to be able to differentiate between delirium and dementia. In an outcome-suryey 6 months after initial assessment, the current living conditions, the independence and the state of health will be determined via the Karnofsky-Index and the European Quality of Life 5 Dimensions-Score (EQ-5D) completed with a cognitive dimension (EQ-6D). For up to two years after the first contact, mortality of the patients will be determined, including the exact date of death. | — |
Countries
Germany
Contacts
Public ContactHannah Zipprich
Universitätsklinikum Jena Hans-Berger-Klinik für Neurologie
Outcome results
None listed